How health policies impact women with autoimmune diseases during pregnancy
Official title: Effects of health policy on the health of people with systemic autoimmune and rheumatic diseases
Funded at University of Pittsburgh at Pittsburgh · NIH-11167103 · Data updated 2026-11-12
This study is looking at how health policies affect women with autoimmune and rheumatic diseases during pregnancy, aiming to understand their experiences and access to care, so we can better support their health and treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | May 25, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $673,538 |
| NIH project number | 1R01HD118690-01 |
| Project ID | NIH-11167103 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women of reproductive age who have been diagnosed with systemic autoimmune and rheumatic diseases and are either pregnant or planning to become pregnant.
✕Less likely to help
Patients who do not have systemic autoimmune or rheumatic diseases or who are not of reproductive age may not benefit from this research.
What this research studies
This research investigates the effects of health policies on women with systemic autoimmune and rheumatic diseases (SARDs), particularly during their reproductive years and pregnancy. It aims to understand how these policies influence access to healthcare, treatment quality, and health outcomes for pregnant individuals with SARDs. The study will involve interviews with patients and rheumatologists to gather insights on their experiences and decision-making processes, as well as analysis of national claims data to assess broader trends. By focusing on the intersection of health policy and reproductive health, this research seeks to highlight the unique challenges faced by this population.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare policies that enhance the health outcomes of women with autoimmune diseases during pregnancy.
How similar studies have gone: While there has been some research on the health outcomes of women with SARDs, this specific focus on health policy's impact is relatively novel and has not been extensively studied.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Talabi, Mehret Birru — University of Pittsburgh at Pittsburgh
- Study coordinator: Talabi, Mehret Birru
Related research
Other NIH-funded projects on the same topics.
-
Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups with Rheumatic Diseases
A patient-facing program tests a multi-modal approach using storytelling videos and trained patient navigators to help Black and Latinx adults with autoimmune rheumatic diseases get recommended COVID-19 vaccines and boosters.
-
How health policies affect people with systemic autoimmune and rheumatic conditions
This project looks at how health policies and medical care affect health and pregnancy outcomes for reproductive-age women with systemic autoimmune and rheumatic diseases.
-
Long-term immune and health effects of COVID-19 in people with autoimmune rheumatic diseases
This project looks at how COVID-19 changes immune responses and causes lingering symptoms in people with autoimmune rheumatic diseases like rheumatoid arthritis and lupus.
-
Training new scientists in rheumatic diseases
This program is training new scientists to explore the causes and treatments of rheumatic diseases, like arthritis, by working together at the University of Pennsylvania and the Children’s Hospital of Philadelphia, so they can help improve care for patients of all ages.
-
Helping Black and Latinx patients with rheumatic diseases get recommended COVID-19 vaccines
This project helps Black and Latinx adults living with autoimmune rheumatic diseases get their recommended COVID-19 vaccines.
-
Effects of COVID-19 on patients with autoimmune diseases
This study is looking at how COVID-19 affects people with autoimmune diseases like rheumatoid arthritis and lupus, to better understand their immune responses and how their treatments might change their reactions to the virus and vaccines, ultimately aiming to improve their health outcomes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.